Marc Benioff | All-In Summit 2024

Salesforce is reorganizing its attention around Agentforce, with Benioff saying the $38 billion, 75,000-person company now has “one focus.” He explicitly ties that discipline to Steve Jobs’s 2010 advice that Apple had only one “A team” and would never pursue more products than fit on his coffee table.

Disney is already using Salesforce’s Atlas/Agentforce stack, which Benioff says solves complex employee problems at more than 90% accuracy and sometimes 95%, with almost no hallucinations. Salesforce also sits across Disney Store, park guides, Disney+, cruises and real estate, giving the agent system unusually broad customer data.

Kaiser is the strongest operating example Benioff gave: he said Agentforce and Atlas handle more than 90% of patient inquiries and scheduling requests across a 20 million-patient system. That includes doctor appointments, CT scans and MRIs, using Kaiser’s Epic data inside an autonomous-agent workflow.

Human-sounding AI customer support is not a future demo in Benioff’s account; Salesforce already has it live. He said callers can interact with an AI they cannot distinguish from a person, and that the capability should be live with thousands of customers before year-end.

Benioff’s main warning is that enterprise AI fails when accuracy, security and trust are treated as secondary. He called Microsoft-era copilots a “complete disaster” and said one homegrown telecom model achieved only about 25% accuracy, arguing that enterprise customers need benchmarked systems rather than internal AI science projects.

Salesforce’s 1-1-1 philanthropy model has become financially material, not symbolic. Benioff said it has produced nearly 10 million volunteer hours, almost $1 billion in grants and free service for nearly 100,000 nonprofits, while the foundation still holds roughly $500 million and was preparing another $25 million for Bay Area public schools.

Benioff’s regenerative-medicine interest is personal as well as philanthropic: he funds Shinya Yamanaka’s research and says he has given nearly $1 billion to UCSF. He described an Achilles procedure using his own plasma, PRP and PF4 that, in his telling, regenerated the damaged tendon, while acknowledging he is not a doctor.

Benioff said Yamanaka once stopped growing brain organoids because he feared they might feel pain, then shifted to growing intestinal tissue for disease research. The story matters less as a verified scientific claim than as evidence of Benioff’s unusually direct access to researchers whose work he funds and discusses privately.